Quest Diagnostics (FRA:QDI) Interest Paid

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:QDI Quest Diagnostics Inc FRA:QDI
74 GF Score
Price €213.70
GF Value €165.38
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Quest Diagnostics Interest Paid?

Interest Paid only applicable to companies reporting Cash Flow from Operations in direct method.

FRA:QDI
74GF Score
Quest Diagnostics Inc FRA:QDI
Interest Paid is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Quest Diagnostics (FRA:QDI) Overvalued in 2026?

Based on GuruFocus' analysis, Quest Diagnostics stock appears to be overvalued. The current stock price of €213.70 is trading 29.2% above its estimated GF Value™ of €165.38. GuruFocus considers Quest Diagnostics to be Modestly Overvalued.

Key valuation signals for FRA:QDI:

  • Interest Paid:
  • GF Value™: €165.38 vs. price of €213.70 (29.2% above fair value)
  • GF Score™: 74/100 with 7 warning signs

No single metric tells the full story. See the FRA:QDI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Quest Diagnostics Business Description

Address 500 Plaza Drive, Secaucus, NJ, USA, 07094
Quest Diagnostics is an independent provider of diagnostic testing, information, and services, primarily in the United States. The company generates most of its revenue from clinical testing, including routine medical tests, anatomic pathology, esoteric testing, and substance abuse testing. Specimens are collected through a national network of patient service centers, as well as physician offices, hospitals, and other collection sites. Quest also operates a smaller Diagnostic Solutions segment that offers clinical trials testing, risk-assessment services, and healthcare information technology solutions. Its customers include physicians, hospitals, health plans, employers, and government health programs. The company primarily earns revenue on a fee-for-service basis, with reimbursement from health insurers, government payers such as Medicare and Medicaid, and direct payments from patients and institutions.
74GF Score

Get the complete analysis for FRA:QDI

Interest Paid is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€213.70
Price
€165.38
GF Value